Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-05-04Clinical Trial Update: Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) [NA]
STEP-BD, a comprehensive treatment program for bipolar disorder, has completed enrollment and is finalizing results assessment. This update …
-
FDA label_change · 2007-04-27FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) from Janssen Pharmaceuticals, Inc. The approval updates the drug's lab…
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder [NA]
A completed clinical trial evaluating galantamine-CR for cognitive dysfunction in bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: Prophylactic Effect of Lamotrigine Compared With Lithium in Bipolar Disorder [Phase 3]
Phase 3 trial comparing lamotrigine to lithium for prophylaxis in bipolar disorder has completed. This update reports the trial results.
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents [Phase 3]
A Phase 3 study completed evaluating the safety of Depakote extended-release tablets in treating mania associated with bipolar disorder in c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder [Phase 4]
A Phase 4 trial comparing divalproex ER and risperidone for bipolar disorder with comorbid substance use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania [Phase 4]
Phase 4 clinical trial update evaluating the combination of olanzapine and carbamazepine for bipolar disorder with mania. The study status i…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder [Phase 4]
Phase 4 trial comparing olanzapine to a comparator and placebo in bipolar I disorder has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response [Phase 4]
A Phase 4 bipolar depression treatment response study sponsored by Eli Lilly and Company has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-04Clinical Trial Update: Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression. [Phase 3]
A Phase 3 trial evaluating Triiodothyronine (T3) supplementation for major depressive disorder and bipolar disorder has been completed.
-
FDA approval · 2006-12-17FDA Approved: VALPROIC ACID — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for valproic acid submitted by Bionpharma Inc.
-
FDA approval · 2006-12-15FDA Approved: VALPROIC ACID — Supplemental Application (Xttrium Laboratories Inc.)
The FDA approved a supplemental application for valproic acid from Xttrium Laboratories Inc., updating the approved ANDA.
-
FDA approval · 2006-12-09FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for EQUETRO (carbamazepine) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2006-11-29FDA Approved: ZYPREXA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA (olanzapine) submitted by Eli Lilly and Company.
-
FDA approval · 2006-11-29FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental NDA to add an intramuscular formulation of ZYPREXA (olanzapine) from Eli Lilly and Company.
-
FDA approval · 2006-10-20FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc.
-
FDA label_change · 2006-10-20FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC, likely involving labeling changes.
-
FDA approval · 2006-10-13FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie. The action updates labeling to reflect the a…
-
FDA label_change · 2006-10-13FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote (divalproex sodium) submitted by AbbVie Inc. This action relates to changes impleme…
-
FDA approval · 2006-10-06FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
The FDA has approved a supplemental application for Risperidone submitted by Janssen Pharmaceutical, Inc.
-
FDA approval · 2006-10-01FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Lithobid (lithium carbonate) submitted by ANI Pharmaceuticals, Inc. This action confirms app…
-
FDA approval · 2006-09-25FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL (lamotrigine) from GlaxoSmithKline LLC, indicating an update to the product label/inten…
-
FDA approval · 2006-09-25FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Lamictal (lamotrigine) from GlaxoSmithKline LLC, resulting in updated labeling to reflect ex…
-
FDA approval · 2006-09-20FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for SEROQUEL (quetiapine) filed by H2-Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: A Study of Risperidone Monotherapy in Bipolar Anxiety [Phase 4]
Phase 4 trial of risperidone monotherapy for bipolar anxiety has completed, examining efficacy in bipolar disorder with co-occurring panic o…